Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
Clinical trial NCT02533765 · COMPLETED
Trial details
- NCT number
- NCT02533765
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-11
- Primary completion
- 2018-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.